EML4-ALK-positive lung cancer is a novel cancer entity associated with light or never smoking, younger age, and adenocarcinoma with acinar or signet-ring cell type histology. Another mutation of ALK with NPM, resulting in NPM-ALK fusion mutation, was described in patients with anaplastic large cell lymphoma (ALCL). It was subsequently reported in organ transplant recipients and patiens undergoing immunosuppressive therapy. We describe a case of lung cancer in a 36-year-old nonsmoking woman with ulcerative colitis treated with azathioprine, who was diagnosed with EML4-ALK-positive, metastatic lung cancer two months postpartum. Crizotinib 300 mg/day has been effective in maintaining response after chemotherapy failed. The resemblance of this case to ALK-positive ALCL in organ transplant recipients suggests that similar mechanisms may be responsible for the development of both ALK-positive lung cancer and ALCL in patients receiving immunosuppressive therapy.
ChiarleR., VoenaC., AmbrogioC., PivaR., InghiramiG.: The anaplastic lymphoma kinase in the pathogenesis of cancer.Nat Rev Cancer, 8: 11–23, 2008.
7.
KueferM.U., LookA.T., PulfordK., BehmF.G., PattengaleP.K., MasonD.Y., MorrisS.W.: Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.Blood, 90: 2901–2910, 1997.
8.
WongD.W., LeungE.L., SoK.K., TamI.Y., SihoeA.D., ChengL.C., HoK.K., AuJ.S., ChungL.P., Pik WongM; University of Hong Kong Lung Cancer Study Group: The EML4-ALK fusion gene is involved in various histologic types of lung cancers from non-smokers with wild-type EGFR and KRAS.Cancer, 115: 1723–1733, 2009.
9.
InamuraK., TakeuchiK., TogashiY., HatanoS., NinomiyaH., MotoiN., MunM.Y., SakaoY., OkumuraS., NakagawaK., SodaM., ChoiY.L., ManoH., IshikawaY.: EML4-ALK lung cancers are characterized by rare other mutations, TTF1 cell lineage, an acinar histology, and young onset.Mod Pathol, 22: 508–515, 2009.
10.
InamuraK., TakeuchiK., TogashiY., NomuraK., NinomiyaH., OkuiM., SatohY., OkumuraS., NakagawaK., SodaM., ChoiY.L., NikiT., ManoH., IshikawaY.: EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.J Thorac Oncol, 3: 13–17, 2008.
11.
ShawA.T., YeapB.Y., Mino-KenudsonM., DigumarthyS.R., CostaD.B., HeistR.S., SolomonB., StubbsH., AdmaneS., McDermottU., SettlemanJ., KobayashiS., MarkE.J., RodigS.J., ChirieacL.R., KwakE.L., LynchT.J., IafrateA.J.: Clinical features and outcome of patients with non-small cell lung cancer who harbor EML4-ALK.J Clin Oncol, 27: 4247–4253, 2009.
12.
MasonD.Y., BastardC., RimokhR., DastugueN., HuretJ.L., KristofferssonU., MagaudJ.P., NezelofC., TillyH., VannierJ.P.: CD30-positive large cell lymphomas (‘Ki-1 lymphoma’) are associated with a chromosomal translocation involving 5q35.Br J Haematol, 74: 161–168, 1990.
13.
Costes-MartineauV., DelfourC., ObledS., LamantL., PageauxG.P., BaldetP., BlancP., DelsolG.: Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.J Clin Pathol, 55: 868–871, 2002.
14.
SebireN.J., MaloneM., RamsayA.D.: Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child.Pediatr Dev Pathol, 7: 290–293, 2004.
15.
MitelmanF., JohanssonB., MertensF.: The impact of translocations and gene fusions on cancer causation.Nat Rev Cancer, 7: 233–245, 2007.
16.
FukuyoshiY., InoueH., KitaY., UtsunomiyaT., IshidaT., MoriM.: EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.Br J Cancer, 98: 1536–1539, 2008.
17.
TakeuchiK., ChoiY.L., TogashiY., SodaM., HatanoS., InamuraK., TakadaS., UenoT., YamashitaY., SatohY., OkumuraS., NakagawaK., IshikawaY., ManoH.: KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.Clin Cancer Res, 15: 3143–3149, 2009.
HernándezL., PinyolM., HernándezS., BeàS., PulfordK., RosenwaldA., LamantL., FaliniB., OttG., MasonD.Y., DelsolG., CampoE.: TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations.Blood, 94: 3265–3268, 1999.
20.
CoulthardS., HogarthL.: The thiopurines: an update.Invest New Drugs, 23: 523–532, 2005.
21.
OffmanJ., OpelzG., DoehlerB., CumminsD., HalilO., BannerN.R., BurkeM.M., SullivanD., MacphersonP., KarranP.: Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation.Blood, 104: 822–828, 2004.
22.
DuensingS., LeeL.Y., DuensingA., BasileJ., PiboonniyomS., GonzalezS., CrumC.P., MungerK.: The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.Proc Natl Acad Sci U S A, 97: 10002–10007, 2000.
23.
CamidgeD.R., KonoS.A., LuX., OkuyamaS., BarónA.E., OtonA.B., DaviesA.M., Varella-GarciaM., FranklinW., DoebeleR.C.: Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed.J Thorac Oncol, 6: 774–780, 2011.
